LINC 2015 Programme

Find all topics and speakers listed below.

Discussion Forum

10 events
  • Tuesday, January 27th: - , Discussion Forum

    Abbott Vascular endovascular electronic education program – below the knee interventions – Panel discussion with recorded cases

    Chairman:
    Max Amor
    Moderator:
    Hans Martin Gißler, Roberto Ferraresi, Luis Mariano Palena, Christian Wissgott
  • Tuesday, January 27th: - , Discussion Forum

    Why I do what I do in challenging or emergency situations

    Chairman:
    Thomas Zeller
    Discussant:
    Bertrand Saint-Lebes, Peter Riley, Daniele Savio, Giorgio Poletto
    1. -

      The GORE® TIGRIS® Vascular Stent for treatment of severe obstructive disease in the external iliac artery

        Bertrand Saint-Lebes
    2. -

      Endovascular treatment of central venous stenosis in emergencies

        Peter Riley
    3. -

      The GORE® VIABAHN® Endoprosthesis in a complex case of double subclavian aneurysm: three years follow-up

        Daniele Savio
    4. -

      Double recanalization in a challenging TASC D lesion: what I have learned

        Giorgio Poletto
  • Wednesday, January 28th: - , Discussion Forum

    Challenges in EVAR: current solutions and future needs

    Chairman:
    Michael Dake
    Discussant:
    Rob Fisher, Giovanni Pratesi, Robert Rhee, Michel Reijnen
    1. -

      Overcoming challenging aortic anatomy: from hostile necks to tortuous iliac arteries

        Rob Fisher
    2. -

      Iliac branching devices – dos and don’ts

        Giovanni Pratesi
    3. -

      Precision and accuracy in treating hostile anatomy: limitations and on-going needs

        Robert Rhee
    4. -

      Discussion and conclusion

  • Wednesday, January 28th: - , Discussion Forum

    VIVA @ LINC: Post-EVAR disasters – how I fix problems when they occur

    Chairman:
    Peter Schneider
    Discussant:
    Michael Dake, Chris Metzger, Gary Ansel
    1. -

      This is a case-based session focussing on what we like best … real cases with challenges and complications that make the experts sweat. In this amphitheatre setting, audience participation is encouraged and step-by-step case management is featured and discussed. This round room setting is dedicated to controversial or interactive talk-show-like sessions

  • Wednesday, January 28th: - , Discussion Forum

    Open questions in the treatment of acute uncomplicated Type B dissection

    Chairman:
    Jan Brunkwall
    Discussant:
    Michael Dake, Michael Jenkins, Thomas Larzon, Santi Trimarchi
    1. -

      Is medical treatment alone the treatment of choice for all patients with uncomplicated Type B dissection?

        Michael Jenkins
    2. -

      Interactive discussion of uncomplicated Type B dissection cases in medical treatment - Case examples

        Thomas Larzon
    3. -

      Panel discussion: What is daily practice treating uncomplicated Type B dissections?

    4. -

      Panel discussion

  • Wednesday, January 28th: - , Discussion Forum

    Abbott Vascular endovascular electronic education program – treatment of the SFA – Panel discussion with recorded cases

    Chairman:
    Yann Gouëffic
    Moderator:
    Jörg Teßarek, Enrico Marone, Lieven Maene
  • Thursday, January 29th: - , Discussion Forum

    Controversial issues and open questions in venous interventions

    Chairman:
    Michael Dake
    Discussant:
    Sebastian Schellong, Nils Kucher, Michael Jaff, Gerard O'Sullivan, Cees Wittens
    1. -

      Venous interventions – Hype or reality?

    2. -

      Most patients are still best treated with anticoagulation – interventions are only justified in very selected cases!

        Sebastian Schellong
    3. -

      The evidence for venous interventions is evolving – many patients do actually benefit!

        Nils Kucher
    4. -

      How to select appropriate endpoints and measure success?

        Michael Jaff
    5. -

      Discussion and conclusion

    6. -

      Are venous interventional techniques ready for prime-time?

    7. -

      Thrombus removal in acute and subacute thrombosis: How to achieve and the role of filter protection

        Gerard O'Sullivan
    8. -

      Venous stenting: How does the optimal device look like and does it already exist?

        Cees Wittens
    9. -

      What is the optimal time window for treating deep venous thrombosis – acute vs. subacute vs. chronic cases

        Peter Schneider
    10. -

      Discussion and conclusion

  • Thursday, January 29th: - , Discussion Forum

    The great debate: Are all DCB equal?

    Chairman:
    Michael Jaff, Dierk Scheinert
    Discussant:
    Gunnar Tepe, Renu Virmani, Stephan Duda, Marianne Brodmann
    1. -

      There are clear differences in DCB outcomes in the SFA for various coatings – DCB are not equal!

        Gunnar Tepe
    2. -

      Lacking head-to-head trials comparing different DCB studies is comparing apples and oranges – Results have been substantially affected by trial design

    3. -

      The relevance of Paclitaxel dose and coating for efficacy and safety

        Renu Virmani
    4. -

      Whats next to come in the drug delivery space: Ongoing DCB programmes

        Stephan Duda
    5. -

      Lessons learned from INPACT.Deep and why we should stay away from DCB for BTK interventions

        Erich Minar
    6. -

      DCB are still a valid option to solve the challenge of BTK vessel patency: Lutonix BTK trials are continuing

        Marianne Brodmann
    7. -

      Discussion and conclusion

  • Thursday, January 29th: - , Discussion Forum

    Meet with the experts of the GORE® VIABAHN® Endoprosthesis

    Chairman:
    Peter Soukas
    Discussant:
    Michel Reijnen, Jorge Fernández Noya, Michele Antonello
    1. -

      What I am still learning with the GORE® VIABAHN® Endoprosthesis

        Michel Reijnen
    2. -

      Best practices for durable results

        Jorge Fernández Noya
    3. -

      How I treat popliteal aneurysm in my daily practice

        Michele Antonello
  • Thursday, January 29th: - , Discussion Forum

    VIVA @ LINC: The worst complication I had this year. What did I learn?

    Chairman:
    Michael Jaff
    Discussant:
    Michael Dake, John Kaufman, Chris Metzger
    1. -

      This is a case-based session focussing on what we like best … real cases with challenges and complications that make the experts sweat. In this amphitheatre setting, audience participation is encouraged and step-by-step case management is featured and discussed. This round room setting is dedicated to controversial or interactive talk-show-like sessions.

Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.

For more infos on the cookies we use and how you can manage them, please visit our cookie policy.

  • We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • Our website makes use of external services such as Issuu and Push-Panda. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.